An effect of puromycin on galactosyltransferase of Golgi-rich fractions from rat liver.
D000241:Adenosine / Q000031:analogs & derivatives / Q000494:pharmacology; D000818:Animals; D001665:Binding Sites; D002021:Buffers; D002250:Carbon Radioisotopes; D003839:Deoxyadenosines / Q000031:analogs & derivatives / Q000494:pharmacology; D005690:Galactose; D005944:Glucosamine / Q000031:analogs & derivatives / Q000494:pharmacology; D006056:Golgi Apparatus / Q000187:drug effects / Q000201:enzymology*; D006602:Hexosyltransferases / Q000378:metabolism*; D007700:Kinetics; D008099:Liver / Q000166:cytology / Q000187:drug effects / Q000201:enzymology*; D008297:Male; D008345:Manganese / Q000494:pharmacology; D010649:Phenylalanine / Q000494:pharmacology; D011092:Polyethylene Glycols; D011485:Protein Binding; D011691:Puromycin / Q000494:pharmacology*; D051381:Rats; D012266:Ribose / Q000494:pharmacology; D013997:Time Factors; D014316:Tritium; D014465:Ultrasonics
D002021:Buffers; D002250:Carbon Radioisotopes; D003839:Deoxyadenosines; D014316:Tritium; D011092:Polyethylene Glycols; D008345:Manganese; D010649:Phenylalanine; D011691:Puromycin; D012266:Ribose; D006602:Hexosyltransferases; D000241:Adenosine; D005944:Glucosamine; D005690:Galactose